These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27445169)

  • 1. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
    Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging.
    Kim HJ; Kim DY; Park JH; Yang SD; Hur MG; Min JJ; Yu KH
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5288-92. PubMed ID: 22796183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of a (68)Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET probe for malignant melanoma.
    Kim HJ; Kim DY; Park JH; Yang SD; Hur MG; Min JJ; Yu KH
    Bioorg Med Chem; 2012 Aug; 20(16):4915-20. PubMed ID: 22831797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
    Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
    Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
    Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
    Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Radiofluorinated Nicotinamide/Picolinamide Derivatives as Diagnostic Probes for the Detection of Melanoma.
    Lo YH; Chang TY; Chen CL; Lin MH; Wang HE; Chang CW; Liu RS; Wu CY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanin-targeted preclinical PET imaging of melanoma metastasis.
    Ren G; Miao Z; Liu H; Jiang L; Limpa-Amara N; Mahmood A; Gambhir SS; Cheng Z
    J Nucl Med; 2009 Oct; 50(10):1692-9. PubMed ID: 19759116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma Imaging Using
    Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
    Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Al
    Palangka CRAP; Hanaoka H; Yamaguchi A; Murakami T; Tsushima Y
    Ann Nucl Med; 2019 Oct; 33(10):733-739. PubMed ID: 31297699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
    Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
    Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma.
    Wu SY; Huang SP; Lo YC; Liu RS; Wang SJ; Lin WJ; Shen CC; Wang HE
    Biomed Res Int; 2014; 2014():912498. PubMed ID: 25254219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN.
    Pan D; Yan Y; Yang R; Xu YP; Chen F; Wang L; Luo S; Yang M
    Contrast Media Mol Imaging; 2014; 9(5):342-8. PubMed ID: 24729577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Imaging of Melanoma Using Melanin-Targeted Probe.
    Ma X; Cheng Z
    Methods Mol Biol; 2021; 2265():407-416. PubMed ID: 33704730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker.
    Zhu C; Xu Q; Pan D; Xu Y; Liu P; Yang R; Wang L; Sun X; Luo S; Yang M
    Contrast Media Mol Imaging; 2016; 11(2):99-105. PubMed ID: 26286841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
    Chen CC; Chen YY; Lo YH; Lin MH; Chang CH; Chen CL; Wang HE; Wu CY
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation of [
    Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S
    Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
    Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
    J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.
    Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y
    Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.